Selection of vasodilator, inotropic or combined therapy for the management of heart failure
- 1 July 1978
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 65 (1) , 181-188
- https://doi.org/10.1016/0002-9343(78)90708-8
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Factors influencing left ventricular shortening in isolated canine heartAmerican Journal of Physiology-Legacy Content, 1976
- Chronic Vasodilator Therapy in the Management of Cardiogenic Shock and Intractable Left Ventricular FailureAnnals of Internal Medicine, 1974
- Treatment of Refractory Heart Failure with Infusion of NitroprussideNew England Journal of Medicine, 1974
- Hemodynamic and Metabolic Responses to Vasodilator Therapy in Acute Myocardial InfarctionCirculation, 1973
- Beneficial Effects of Vasodilator Agents in Severe Mitral Regurgitation Due to Dysfunction of Subvalvar ApparatusCirculation, 1973
- IMPROVED LEFT VENTRICULAR FUNCTION DURING NITROPRUSSIDE INFUSION IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1972
- PHENTOLAMINE FOR VASODILATOR TREATMENT OF SEVERE HEART-FAILUREThe Lancet, 1971
- Dopamine in the Treatment of Hypotension and ShockNew England Journal of Medicine, 1966
- Homeometric Autoregulation in the HeartCirculation Research, 1960
- The hemodynamic response of man to nor-epinephrine and epinephrine and its relation to the problem of hypertensionThe American Journal of Medicine, 1948